CM
DNA icon

Caption Management’s Ginkgo Bioworks DNA Stock Holding History

Caption Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-15,000
Closed -$219K – 1681
2025
Q3 		$219K Buy
+15,000
New +$179K ﹤0.01% 1455
2025
Q1 		– Sell
-19,998
Closed -$196K – 1643
2024
Q4 		$196K Sell
19,998
-95,674
-83% -$820K ﹤0.01% 1280
2024
Q3 		$943K Buy
+115,672
New +$1.16M 0.02% 792
2022
Q1 		– Sell
-1,005
Closed -$334K – 1563
2021
Q4 		$334K Buy
+1,005
New +$477K ﹤0.01% 1348

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Caption Management's DNA Position: Q4 2025 in Review

Caption Management sold out of Ginkgo Bioworks (DNA) in Q4 2025, closing a stake of 15,000 shares — an estimated $219K sold.

Caption Management first reported a position in DNA in Q4 2021 and held it in 4 quarters. The position peaked at $943K in Q3 2024. 180 funds tracked by Wall St. Rank hold DNA as of Q4 2025.

  • Caption Management reported no remaining Ginkgo Bioworks position as of Q4 2025 after selling out during the quarter.
  • Caption Management sold 15,000 Ginkgo Bioworks shares in Q4 2025, an estimated $219K.
  • Caption Management first reported a position in Ginkgo Bioworks in Q4 2021 and held it in 4 quarters.
  • Caption Management's Ginkgo Bioworks position peaked at $943K in Q3 2024.
  • 180 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2025.

Based on Caption Management's 13F filing for Q4 2025, filed 17 Feb 2026.